Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Is Bluebird Bio Stock a Buy?
Prosper Junior Bakiny
|
May 16, 2024
It won't be easy for the company to bounce back.
Is Bluebird Bio Stock a Buy?
Alex Carchidi
|
Apr 15, 2024
This small biotech is struggling to fly -- and investors should probably steer clear.
Better Buy: Bluebird Bio Vs. Novavax
Prosper Junior Bakiny
|
Apr 13, 2024
Who wins this face-to-face between two beaten-down biotechs?
Is This Beaten-Down Stock a Good Acquisition Target?
Prosper Junior Bakiny
|
Apr 11, 2024
This company has proven its innovative abilities, but that's not enough to outperform the market.
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
Eric Volkman
|
Mar 29, 2024
Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.
Why Bluebird Bio Stock Flew Higher Than the Market Today
Eric Volkman
|
Mar 18, 2024
The company was thrown a financial lifeline.
Why Bluebird Bio Stock Dived Into the Red on Tuesday
Eric Volkman
|
Mar 5, 2024
The biotech has had a tough time of it over the past few years; a pundit's revised take on the company won't improve that situation.
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
Prosper Junior Bakiny
|
Jan 27, 2024
The answer hardly inspires confidence.
2 Red Flags for Bluebird Bio Stock
Prosper Junior Bakiny
|
Jan 10, 2024
The biotech's struggles may continue.
View More Articles